calendar
8,998 catalysts · 3,288 8k filing · 1,751 grant · 1,000 device adverse event · 820 approval · 632 device 510k · 584 earnings
next 91 dayslessmore
MonWedFri
8,998 catalysts · 3,288 8k filing · 1,751 grant · 1,000 device adverse event · 820 approval · 632 device 510k · 584 earnings
Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: REMPEX. Form: POWDER. Route: INTRAVENOUS
Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION
Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION
Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION
Product code: OBP. Advisory committee: Neurology. Type: Traditional
Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Advisory committee: Unknown. Type: Traditional
Product code: JOJ. Advisory committee: General Hospital. Type: Special
Product code: FAD. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: FQH. Advisory committee: General Hospital. Type: Traditional
Product code: OLO. Advisory committee: Neurology. Type: Traditional
Product code: FMK. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: OWB. Advisory committee: Radiology. Type: Traditional
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Product code: MQL. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional
Product code: JFY. Advisory committee: Clinical Chemistry. Type: Traditional
Supplement type: Normal 180 Day Track No User Fee. Product code: SDL. Advisory committee: AN. Decision: APPR
Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30
Product code: LTI. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30
Supplement type: Normal 180 Day Track No User Fee. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: OUT. Advisory committee: NE. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MLV. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: DTB. Advisory committee: CV. Decision: OK30
Supplement type: Real-Time Process. Product code: LOZ. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: PFN. Advisory committee: NE. Decision: OK30
Supplement type: Normal 180 Day Track. Product code: QMG. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30
AI grant. $899,850. PI: Sebastian Lourido
DK grant. $741,387. PI: Irina Bancos
AI grant. $481,520. PI: Tyler Nelson Starr
AI grant. $804,705. PI: Chih-Ming Tsai
AI grant. $713,107. PI: Alon Herschhorn
GM grant. $75,052. PI: Elijah Noam Allen Kissman
AI grant. $251,563. PI: Carolina Lucas
AI grant. $449,393. PI: Leigh Knodler
AI grant. $489,500. PI: Estelle Bettelli
AI grant. $862,347. PI: Whitney Elizabeth Harrington
AI grant. $233,790. PI: Michael L Freeman
AI grant. $439,375. PI: David J Gonzalez
AI grant. $760,277. PI: Brian T Fife
AI grant. $2,684,352. PI: Eddie A James
AI grant. $766,730. PI: Richard L Gallo
DK grant. $326,208. PI: Neha Pravin Gothe
AI grant. $427,313. PI: ANDREW P LANE